These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 632119)

  • 1. [Thrombocyte replacement].
    Fröhlich C
    Hippokrates; 1978 Feb; 49(1):95-7. PubMed ID: 632119
    [No Abstract]   [Full Text] [Related]  

  • 2. [The HLA crossmatching test before thrombocyte transfusion. Comparison of 3 methods].
    Májský A; Prazák J
    Vnitr Lek; 1990 Sep; 36(9):873-8. PubMed ID: 2251774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in HLA typing.
    Duquesnoy RJ
    Prog Clin Biol Res; 1982; 88():125-42. PubMed ID: 6808523
    [No Abstract]   [Full Text] [Related]  

  • 4. [Obtaining, storage and use of test reagents for tissue typing in allogeneic transplantation and blood transfusion (methodological recommendations)].
    Lab Delo; 1976; (10):630-8. PubMed ID: 63607
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet replacement therapy: a clinical assessment.
    Hester JP; McCredie KB; Freireich EJ
    Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
    [No Abstract]   [Full Text] [Related]  

  • 6. Human histocompatibility antigens (HLA).
    Kumar R; Mittal KK
    Indian Pediatr; 1983 Oct; 20(10):763-70. PubMed ID: 6373600
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to HLA typing.
    Azadeh B; Alla AD
    Middle East J Anaesthesiol; 1986 Oct; 8(6):511-7. PubMed ID: 3537673
    [No Abstract]   [Full Text] [Related]  

  • 9. Supportive haemotherapy in bone marrow transplantation.
    Mayr WR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):455-8. PubMed ID: 2480289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe aplastic anemia treated with HLA-matched platelet transfusion].
    Nozaki H; Yonekura S; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1986 Aug; 27(8):1410-4. PubMed ID: 3795515
    [No Abstract]   [Full Text] [Related]  

  • 11. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
    Májský A; Fortýnová J; Vopatová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion.
    Narimatsu H; Wake A; Miura Y; Tanaka H; Matsumura T; Takagi S; Kato D; Myojo T; Kusumi E; Masuoka K; Miyakoshi S; Morinaga S; Saji H; Ichinohe T; Taniguchi S
    Bone Marrow Transplant; 2005 Sep; 36(6):555-6. PubMed ID: 16007108
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renewal of organ transplantation: towards the control of rejection].
    Bach JF
    Rev Prat; 1986 May; 36(29):1615-9. PubMed ID: 3487822
    [No Abstract]   [Full Text] [Related]  

  • 14. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of sharing major histocompatibility complex and minor antigens between blood and graft donors in the blood transfusion effect.
    Peugh WN; Wood KJ; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):744-5. PubMed ID: 3274861
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of matched platelet transfusions from unrelated donors.
    Radvany R; Green D; Rossi EC; Draugelis AK; Kahan BD
    Transplant Proc; 1977 Mar; 9(1):513-7. PubMed ID: 867499
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the effects of cyclosporine and HLA-typed source leukocyte transfusions (apheresis by-products) on the immune systems of highly sensitized prospective renal allograft recipients.
    Weir MR; Shen SY; Dagher FJ; Bentley FR; Lesko L; Sadler JH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):735-7. PubMed ID: 3547838
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation.
    Taaning E; Jacobsen N
    Transplant Proc; 1994 Jun; 26(3):1826. PubMed ID: 8030157
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].
    Kubel M; Freistedt B; Hammer P; Thierbach V; Helbig W; Haustein B; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):355-64. PubMed ID: 6179839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the patient alloimmunized to platelets.
    Tomasulo PA; Doddridge D; Reynolds AW
    J Fla Med Assoc; 1984 Jun; 71(6):397-9. PubMed ID: 6544323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.